Prof. Dr. Alessandro Ceschi M.d., M.sc., Eucp, Feapcct, Frcpe

Prof. Dr. Alessandro Ceschi, M.D., M.Sc., EuCP, FEAPCCT, FRCPE has a diverse and extensive work experience. Since 2015, they have held various roles at the Ente Ospedaliero Cantonale (EOC), including Chief - Medical Education and Research, Medical and Scientific Director - Institute of Pharmacological Sciences of Southern Switzerland, Chief Physician - Clinical Pharmacology and Toxicology & Regional Pharmacovigilance Centre, Director - Clinical Trial Unit (CTU-EOC), Chairman - Drug and Therapeutics Committee, Executive Board Member - Lugano Hospital, Member - EOC Research Board, Deputy Chief - Academic Education, Research and Innovation Area, Coordinator - COVID-19 Vaccines Working Group, Chairman - Scientific Committee COVID-19, and Coordinator - Accompanying group EOC-Faculty Biomedical Sciences University of Southern Switzerland.

Starting from 2023, Prof. Ceschi will also serve as Vice President and Steering Committee Member at Switzerland Innovation Park Ticino | Site of Park Zurich. In addition, they have worked as a Consultant at the University Hospital Zürich since 2013 and as a Professor of Medicine in Clinical Pharmacology and Toxicology at USI Università della Svizzera italiana since 2019. Prof. Dr. Alessandro is also involved in teaching and research activities at the University of Zurich as a Senior Lecturer and at the University of Basel as a Lecturer.

Prof. Ceschi has contributed their expertise to various organizations and associations, including Swissmedic, where they serve as an Expert and Member in the Swiss Agency for Therapeutic Products Taskforce COVID Pharmacovigilance. Prof. Dr. Alessandro is also actively involved with the World Health Organization (WHO) as an Academic Advisor for the WHO Medication Safety Policy Brief, an Expert in the WHO Global Patient Safety Challenge Medication Without Harm, and a Member of the WHO Global Patient Safety Network.

Additionally, they have held leadership positions within the Swiss Society of Clinical Pharmacology and Toxicology (SSCPT) as a Board Member and the Swiss Group of Pharmacogenomics and Personalised Therapy (SPT) as a Steering Committee Member.

Overall, Prof. Dr. Alessandro Ceschi has an impressive work experience in the field of medicine, clinical pharmacology, toxicology, research, education, and leadership, with a focus on medication safety and personalized therapy.

Prof. Dr. Alessandro Ceschi, M.D., M.Sc., EuCP, FEAPCCT, FRCPE has an extensive education history in medicine. Prof. Dr. Alessandro obtained their Doctor of Medicine (M.D., Dr. med.) degree from the University of Zurich in 2005. Prof. Dr. Alessandro further pursued their medical education at the same university and earned a Swiss Medical Diploma - Master's degree in an unspecified field of study in 2004.

Later, Prof. Dr. Ceschi focused on specialization and advanced degrees. Prof. Dr. Alessandro completed their habilitation, earning a Venia Legendi (PD Dr. med.) in Medicine from the University of Zurich, with the year of completion unspecified, but it falls before 2015.

In 2017, they attended Université de Bordeaux and pursued a Master of Science - MSc degree in the European Programme in Pharmacovigilance and Pharmacoepidemiology (Eu2P), which they successfully completed in 2019.

Continuing their academic journey, Prof. Dr. Ceschi obtained a Titularprofessur (Prof. Dr. med.) in Medicine from USI Università della Svizzera italiana in an unspecified year.

Prof. Dr. Ceschi also holds additional board certifications from the Swiss Medical Association (FMH). Prof. Dr. Alessandro is board-certified in Clinical Pharmacology and Toxicology and General Internal Medicine. The specific years of obtaining these certifications are not provided.